Story thread · 3 reports / 3 sources

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

gpb.org · 10dShare

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

First report: FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned — npr.org, 10d